Navigation Links
Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
Date:10/14/2008

TAMPA, Fla., Oct. 14 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today preliminary results from a pivotal anterior uveitis trial that compared Durezol(TM) (difluprednate ophthalmic emulsion) 0.05% dosed four times daily (QID) to Pred Forte(R) (prednisolone acetate ophthalmic suspension) 1%, dosed eight times daily. Durezol is a topical ophthalmic corticosteroid indicated for the treatment of inflammation and pain associated with ocular surgery; it was approved by the US Food and Drug Administration in June 2008. Pred Forte(R) is the registered trademark of Allergan, Inc.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080220/CLW064LOGO )

Ninety patients with endogenous anterior uveitis were studied in a multicenter, randomized, double-masked trial that compared the efficacy and safety of Durezol QID with Pred Forte eight times a day. Treatment for both study groups was administered for 14 days, with 2 weeks of tapering at half the dose and 2 weeks of follow-up (for a total 42 days) after initiation of therapy.

The primary endpoint was the difference from baseline in anterior chamber (AC) cell grades between the Durezol and Pred Forte groups. At Day 14, the Durezol group achieved a mean cell grade reduction of 2.1, compared to 1.9 in the Pred Forte group, confirming the noninferiority of Durezol dosed QID to Pred Forte dosed eight times a day.

"This study shows that Durezol is a potent steroid that can be used effectively four times a day to reduce inflammation in patients with moderate to severe uveitis," explained C. Stephen Foster, MD, an investigator in the trial and the founder and president of the Massachusetts Eye Research and Surgery Institution. "This is especially important since the US standard of care currently necessitates dosing steroids every hour -- and as frequently
'/>"/>

SOURCE Sirion Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
2. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... TARRYTOWN, N.Y. , May 23, 2013 /PRNewswire/ ... reconstruction following mastectomy is an appropriate option ... mutations seeking to surgically reduce their breast cancer ... involves a gradual expansion process and a second ... of implants in the same surgery as mastectomy ...
(Date:5/23/2013)... -- Net Medical Xpress Solutions, Inc., (OTC QB: NMXS), a ... has signed a letter of intent to acquire MedTel ... Huntsville, AL . MedTel Solutions is a physician ... of telemedicine physicians. Consideration for the acquisition will be ... expected by June 30, 2013. Dick Govatski, ...
(Date:5/23/2013)... AVIV, Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s ... place on October 14 th -15 th in ... nd most innovative city in the world by the ... "Start-up Nation." BrainTech Israel 2013 will showcase the ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... Stem Cell Sciences From University of Cambridge ... - ("Stem Cell Sciences", "SCS", "the Company"), ... STEM, ASX: STC), a company focused on the commercialisation ... paper describing a technique,for reprogramming adult mammalian cells into ...
... Sourced from China Shows Strong Results Presented at ... Cambridge Healthtech Institute Fall Conference, BOSTON, ... Bioscience International (HUYA) today described the,preclinical profile and outcome ... China by Chipscreen Biosciences, Ltd. of Shenzhen. The,clinical trial ...
Cached Medicine Technology:Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 2Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology 3Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer 2Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer 3Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer 4Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer 5
(Date:5/23/2013)... May 23, 2013 Sika Sarnafil ... waterproofing membranes, today announced Imperial Roof Systems of Iowa ... professionalism and dedication to quality during the re-roofing of ... Systems is a Sika Sarnafil Elite contractor and one ... Roof Systems is committed to sustainable building practices and ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... by JD Media Surge, LLC. Targeting members of the ... services online and attract new patients, the consulting service ... Internet marketing strategies. , The medical Internet marketing agency ... struggling to get results online. As part of the ...
(Date:5/23/2013)... Retül University , the market leader ... formation of a strategic educational partnership with Ero ... a bike industry first “Positioned for Speed” course combining ... trial, road and triathlon bike fit. , This course ... with a Retül University, F.I.S.T. or S.I.C.I fit certification. ...
(Date:5/23/2013)... Rapids, IA (PRWEB) May 23, 2013 Diversity ... Creative Corridor have an expanded understanding of diversity. The ... The survey was done from February-March of this year. 1198 ... survey as a follow up to its benchmark survey in ... top factors reported in the definition of diversity were race ...
(Date:5/23/2013)... By Dennis Thompson HealthDay Reporter , , THURSDAY, ... taken by millions to lower their cholesterol, but the ... their cardiovascular health through exercise, researchers say. A ... to make any significant fitness gains while taking a ... not on the drug but undergoing the same exercise ...
Breaking Medicine News(10 mins):Health News:Sika Sarnafil Announces Recycling Project of the Year Winner 2Health News:Healthcare Internet Marketing Consulting Services Launched by JD Media Surge 2Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 2Health News:Retül, Ero Sports and Alphamantis Partner for Industry First Aero Fit Course 3Health News:Diversity Focus Announces Results from the 2013 Creative Corridor Community Survey 2Health News:Statins May Hamper Workout Results 2Health News:Statins May Hamper Workout Results 3
... , , WASHINGTON, Aug. 24 In response ... and Cardiovascular H ealth: A Scienti f ic State m ... journal Circulat i on, Dr. Maureen Storey, senior vice ... for t h e America n Beverage A ...
... , Proposed Medicare Cuts Will Harm Seniors, Care, Place ... Jeopardy , , Study Finds California Seniors Hit ... Calif., Aug. 24 A new American Health Care Association analysis of ... recently-enacted Medicare regulation cutting Medicare-funded nursing home care by $12 billion over ...
... RESEARCH TRIANGLE PARK, N.C., Aug. 24 GlaxoSmithKline ... of Advair Diskus(R) (fluticasone propionate and salmeterol inhalation powder) medication ... near Richmond, Virginia. Medicine in the stolen cartons could ... the legitimate supply chain and the storage conditions under which ...
... , NASHVILLE, Tenn., Aug. 24 Cumberland ... it will report second quarter 2009 financial results before the market ... live Internet webcast will be held on Thursday, August 27, 2009 ... , To participate on the call, please dial 877-604-9672 ...
... , , , - ... flawed document he says "pushes pulling the plug." , ... of the national non-profit organization Aging with Dignity, today called on ... "Your Life, Your Choices" advance care planning guide dubbed "The Death ...
... down the disease, study says , MONDAY, Aug. 24 ... very early stages of Alzheimer,s disease might become hyperactive ... , Researchers from the Cleveland Clinic tested 69 mentally ... Alzheimer,s disease because of family history or genetic markers. ...
Cached Medicine News:Health News:American Beverage Association Response to American Heart Association Statement on Added Sugars 2Health News:New Study of House Health Reform Bill: California Faces Over $3.7 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years 2Health News:GSK Advisory: Warehouse Theft 2Health News:Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009 2Health News:Veterans Administration Must Suspend Use of So-Called 'Death Book' on Veterans, Malley Says 2Health News:MRI Might Find Early Alzheimer's 2
... the Marco Keratometer I and ... instruments for objectively measuring corneal ... the added feature of internal ... or those who prefer to ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
Medicine Products: